Skip to content
Search

Latest Stories

NHSE launches training programme to expand community pharmacy roles

The NHS England has introduced a training programme for 1000 staff to broaden their community pharmacy roles, thereby improving patient access to services. Among them, 500 pharmacy staff will be trained to supervise pharmacists during prescription training, while the remaining 500 will provide support for various training, including pre and post-registration programmes for pharmacists and pharmacy technicians.

According to the NHSE, pharmacist and pharmacy technician roles are rapidly evolving due to healthcare changes and increased demand for clinical services in community pharmacy. “There are 3,000 independent prescribing training spots available for 2023/24. Educational supervision is a crucial part of this to enable the ongoing transformation and skills development of the growing pharmacy workforce.”


The NHSE-funded training, scheduled to begin next month, will ensure that those involved in educational supervision, including Designated Supervisors (DSs), Pre-registration Trainee Pharmacy Technician education supervisors and Designated Prescribing Practitioners (DPPs), can effectively support learners.

The NHSE said that both pharmacists and pharmacy technicians are eligible to apply for education supervisor training. "Regulatory changes in 2019 expanded the opportunity for any experienced independent prescriber to seek DPP training."

The training will flexibly accommodate work schedules, enabling learners to enhance their skills and knowledge in providing educational supervision, all while prioritising patient safety and person-centred care, the NHSE added. The implementation of the programme will be conducted by ProPharmace Ltd, under the coordination of the Pharmacy Integration Programme at NHS England.

"This aligns with NHS England's strategy to enhance access to prescribing supervision in community pharmacy," said David Webb, Chief Pharmaceutical Officer at NHSE. "Our goal is to foster a culture in which current pharmacist independent prescribers transition into Designated Prescribing Practitioners and Designated Supervisors as part of their career progression. This effort forms part of our overarching work to prepare the NHS to mentor and support the incoming wave of pharmacist independent prescribers starting in 2026."

"Leveraging their expertise, Education Supervisors will facilitate the training of a greater number of pre and post-registration Pharmacy Technicians, nurturing their clinical responsibilities and services, thereby reinforcing reforms and ensuring sustainability for the future,” said Liz Fidler, Senior Professional Advisor for Pharmacy Technician Practice at NHSE.

“These programmes will provide an innovative approach to developing Educational Supervisors and Designated Prescribing Practitioners, considering individual learning needs and career aspirations,” said Noma Al-Ahmad, Managing Director, ProPharmace. "We eagerly look forward to aiding NHS England in achieving superior supervision standards as a central priority for transforming and enhancing the community pharmacy workforce."

For registration and further details regarding the training program, including eligibility criteria, visit the ProPharmace website.

More information about the Pharmacy Integration Programme and training opportunities for pharmacy professionals can be found on the Health Education England website.

Meanwhile, the NHS is expanding its blood pressure screening services to diverse local sites, such as barbershops, mosques, and pharmacies, to tackle the rising risk of strokes and heart attacks in men.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less